U.S. Specialized REITs Stock News

What Comstock Resources' latest earnings mean for shareholders Comstock Resources (CRK) has released second quarter 2026 results, giving investors a fresh look at how the Haynesville focused gas producer is performing across revenue, profit and production volumes. The company reported second quarter revenue of US$353.28 million compared with US$470.26 million a year earlier, and net income of US$8.77 million compared with US$124.84 million. Basic and diluted earnings per share from continuing...

Church & Dwight (CHD) is back in focus after releasing second quarter 2026 results alongside updated guidance, including modestly higher full year sales and earnings expectations plus fresh commentary on portfolio changes affecting upcoming quarterly revenue. See our latest analysis for Church & Dwight. The earnings beat and raised full year guidance have come alongside steady gains in Church & Dwight’s share price, with a 19.57% year to date share price return and a 25.59% five year total...

A. O. Smith reported its second-quarter 2026 results with sales of US$1,004.3 million and net income of US$124.9 million, alongside updated full-year guidance calling for net sales of US$3.90–3.95 billion and diluted EPS of US$3.60–3.75. The company’s continued share repurchases and focus on North American boiler strength contrasted with weaker China performance and softer residential water heater demand, shaping how investors assess its earnings quality. Next, we’ll examine how weaker China...

In July 2026, Celldex Therapeutics reported topline results from its Phase 2 clinical trial in prurigo nodularis, marking an important milestone for this program in a challenging chronic skin disease. This update is particularly important because it helps clarify the clinical trajectory of Celldex’s dermatology pipeline, a key area of focus for the company’s development efforts. We’ll now examine how the Phase 2 prurigo nodularis results could influence Celldex Therapeutics’ investment...

Kilroy Realty (KRC) is back in focus after second quarter 2026 results showed lower sales and net income versus a year earlier, while management reaffirmed full year earnings guidance and outlined a disciplined acquisition approach. See our latest analysis for Kilroy Realty. The recent second quarter report, guidance reaffirmation, acquisition commentary and ESOP related shelf registration have coincided with mixed momentum in Kilroy Realty’s stock, with a 15.4% 90 day share price return and...

e.l.f. Beauty (ELF) is back in focus for investors after recent share price moves, with the stock closing at US$82.89. The company’s multi-brand cosmetics and skin care portfolio keeps drawing attention. See our latest analysis for e.l.f. Beauty. Across recent timeframes, e.l.f. Beauty’s share price has shown strong momentum, with a 7-day share price return of 7.15% and a 90-day share price return of 37.03%, even though the 1-year total shareholder return declined 28.8%. If you are looking...

Recently, analysts upgraded China Yuchai International to a top Zacks Rank, citing a stronger projected earnings outlook and a trend of higher earnings estimates, bringing fresh attention to the company. An interesting angle is that this improved outlook comes alongside concerns about rising research and development spending and possible regulatory headwinds, which could influence how investors weigh growth against risk. Next, we’ll examine how this upgraded earnings outlook may reshape...

In the past week, Ryan Specialty Holdings reported second-quarter 2026 results showing revenue of US$916.65 million and net income of US$42.32 million, alongside a quarterly dividend of US$0.13 per Class A share and completion of a US$300 million share repurchase program covering 6.71% of shares. Management also highlighted its disciplined acquisition engine and reiterated confidence in a durable platform, even as updated 2026 guidance anticipates some margin pressure despite continued...

Why Tidewater’s Upcoming Q2 Earnings Matter For Investors Tidewater (TDW) is back in focus after confirming it will report Q2 2026 results after the market close on August 3. This earnings release is a key update for investors following mixed performance last quarter. See our latest analysis for Tidewater. Over the past year, Tidewater has combined a 43.71% year to date share price return with a 57.92% one year total shareholder return. However, momentum has cooled recently, with the share...

Jacobs Solutions Inc. has declared a quarterly cash dividend of US$0.36 per share, payable on September 18, 2026 to shareholders of record as of August 21, 2026, and earlier this year LA Metro selected Jacobs, with Clark Construction Group, to design and build advanced zero-emission bus charging infrastructure at two key Los Angeles divisions. The LA Metro win positions Jacobs at the center of Los Angeles’ zero-emission transit preparations for the 2028 Olympic and Paralympic Games while...

Stifel Financial (SF) reported second quarter 2026 results on July 22, with revenue of US$1,638.78 million and net income of US$226.48 million, alongside continued share repurchases during the period. See our latest analysis for Stifel Financial. The stronger second quarter results and ongoing buybacks come after a mixed price pattern for Stifel Financial, with a 15.39% 1 month share price return but a 3.07% decline year to date. At the latest share price of US$82.91, that sits alongside a...

Q3 results and updated guidance set the tone for Tetra Tech Tetra Tech (TTEK) is back in focus after releasing third quarter earnings on July 29, 2026, alongside updated guidance for the fourth quarter and full year, plus a higher quarterly dividend. The company reported third quarter sales of $1,308.56 million compared with $1,369.82 million a year earlier. Net income was $109.58 million, slightly below $113.84 million in the prior year period. Basic and diluted earnings per share from...

Lincoln Electric earnings update and what it means for investors Lincoln Electric Holdings (LECO) recently reported its second quarter and first half 2026 results, giving you fresh information on sales, earnings and ongoing dividend income to reassess the stock. For the second quarter ended June 30, 2026, Lincoln Electric reported sales of $1,219.66m compared with $1,088.67m in the same period last year. Net income was $158.52m compared with $143.40m a year earlier. Basic earnings per share...

Minerals Technologies Inc. has reported past second-quarter 2026 results showing sales of US$548.4 million, up from US$528.9 million a year earlier, but swinging from net income of US$45.4 million to a net loss of US$183.6 million, alongside affirming a quarterly dividend of US$0.12 per share payable in September 2026. Despite higher sales, the sharp move to a basic loss per share of US$5.90 from earnings of US$1.44 highlights significant pressure on profitability that investors may need to...

In the past quarter, Moderna, Inc. reported second-quarter 2026 revenue of US$145 million versus US$142 million a year earlier, with a net loss of US$782 million and basic loss per share from continuing operations of US$1.97, while also updating investors on its norovirus and influenza vaccine programs. Across the first half of 2026, revenue rose to US$534 million from US$250 million, but the net loss widened to US$2.13 billion and basic loss per share from continuing operations increased to...

Piedmont Realty Trust (PDM) has moved into focus after reporting second quarter 2026 results that showed modest year over year growth in sales and revenue, along with a smaller net loss. See our latest analysis for Piedmont Realty Trust. Since those results on 28 July 2026, Piedmont Realty Trust’s share price has eased 2.7% over one day and 1.0% over the week. However, a 16.3% 90 day share price return and 32.4% one year total shareholder return indicate momentum building from earlier in the...

NewAmsterdam Pharma and Menarini Group previously announced that the EMA’s CHMP issued a positive opinion recommending marketing authorization for Ubeslo (obicetrapib 10 mg) and Evlarco (obicetrapib 10 mg plus ezetimibe 10 mg) in European patients with primary hypercholesterolemia and mixed dyslipidemia. This opinion, backed by extensive Phase 2 and Phase 3 data showing meaningful LDL-C reductions with placebo-like tolerability, could reshape NewAmsterdam’s commercial outlook through...

What Flowserve’s latest earnings and guidance updates mean for investors Flowserve (FLS) recently issued second quarter and six month 2026 results alongside revised full year and new third quarter guidance, giving investors fresh data on sales trends, profitability and updated growth expectations. The company now projects approximately 3% total sales growth for 2026, compared with its earlier 3% to 6% range. For the third quarter, Flowserve expects mid single digit total sales growth and net...

In July 2026, CNO Financial Group, Inc. raised its full-year 2026 operating earnings per share guidance by 8% at the midpoint, citing strong underlying fundamentals, improving profitability, and consistently repeatable results across its business. This upgraded outlook underscores management’s confidence in the durability of CNO’s operating model, reinforcing earlier expectations for margin expansion and more efficient capital deployment. Now we’ll examine how the upgraded 2026 operating...

AXT, Inc. reported second-quarter 2026 results showing sales of US$47.59 million and net income of US$11.13 million, alongside a long-term indium phosphide supply and capacity reservation agreement with Lumentum Operations, LLC that includes US$87,000,000 in deposits applied as shipment credits through 2031. These developments mark a shift from prior-period losses to profitability while securing multi-year product demand and upfront customer funding that could influence how investors view...

Caterpillar stock in focus as AI data center theme meets upcoming earnings Caterpillar (CAT) is back on investors’ radar after recent analyst commentary highlighted its role in AI data center construction, with this AI driven demand story now intersecting with the company’s upcoming earnings report. See our latest analysis for Caterpillar. Caterpillar’s share price has been under pressure ahead of earnings, with a 30 day share price return that is down 17.81% and a 90 day share price return...

Upcoming Q2 report puts Douglas Dynamics in focus Douglas Dynamics (PLOW) is set to report its Q2 2026 results before the market opens on Monday, August 3, followed by an earnings call the same day, putting fresh attention on the stock. The market currently expects revenue to grow 12.9% year on year for the quarter, compared with a 2.8% decline in the same period last year. Analyst forecasts have generally been reaffirmed over the past month, indicating limited recent changes in external...

Arrowhead Pharmaceuticals recently reported that its Phase 3 SHASTA-3 and SHASTA-4 trials of plozasiran in severe hypertriglyceridemia met all primary and secondary endpoints, and it also completed global Phase 3 YOSEMITE trial enrollment for zodasiran in homozygous familial hypercholesterolemia. These advances signal meaningful momentum in Arrowhead’s late-stage cardiometabolic RNAi pipeline, potentially broadening future treatment options across rare and severe lipid disorders. Next, we’ll...

How Old National Bancorp’s latest earnings event frames the stock Old National Bancorp (ONB) has drawn fresh attention after reporting second quarter 2026 results that included higher net interest income and net income compared with a year earlier, along with a completed share repurchase tranche and steady net charge offs. See our latest analysis for Old National Bancorp. Old National Bancorp’s recent earnings update and completed buyback have come alongside firm share price momentum, with an...